Wave Life Sciences (WVE) Curent Deferred Tax Liability (2016)

Wave Life Sciences (WVE) posted Curent Deferred Tax Liability of $25000.0 for Q2 2016.

Wave Life Sciences (WVE) Curent Deferred Tax Liability (2016) Analysis & Trends

Wave Life Sciences' Curent Deferred Tax Liability history runs 1 years deep, the most recent figure standing at $25000.0 for Q2 2016.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Curent Deferred Tax (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	-
4	NuCana	279.75 Bn	279.75 Bn	-	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	-
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	-
7	Belite Bio	62.51 Bn	62.51 Bn	-	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	-
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	-
10	Wave Life Sciences	1.16 Bn	612.38 Mn	-	-

Download Data

Date	Value
Jun 30, 2016	25,000.00
Jun 30, 2016	25,000.00